TABLE 2.
Antibody fragment | Aαa | Aβa | k1b | k2b | t½ c | t½ c | AUCd |
---|---|---|---|---|---|---|---|
%ID/g | %ID/g | 1/h | 1/h | h | h | ||
Wild type | 29.6 | 20.3 | 0.2497 | 0.01737 | 2.776 | 39.89 | 938.3 |
H435R | 22.6 | 14.4 | 0.2042 | 0.0165 | 3.394 | 42.02 | 710.6 |
H435Q | 21.2 | 22.2 | 1.244 | 0.06761 | 0.5573 | 10.25 | 361.6 |
I253A | 8.7 | 28.6 | 0.9073 | 0.07431 | 0.764 | 9.328 | 427.1 |
H310A | 13.2 | 17.6 | 1.108 | 0.09282 | 0.6258 | 7.468 | 217.3 |
H310A/H435Q | 52.8 | 26.1 | 3.766 | 0.1083 | 0.1841 | 6.401 | 288.2 |
a Amplitudes of the two components are given by Aα and Aβ, where the sum of Aα and Aβ is the total injected dose/g (%ID/g).
b k1 and k2 are first-order rate constants for distribution and elimination, respectively.
c t½α and t½β are the distribution and elimination phase half-lives and are calculated by ln2/k1 and ln2/k2, respectively.
d Area under the curve is a time integral of the blood uptake (%ID/g·h).